Hound Partners’s Molecular Partners MOLN Stock Holding History

Hound Partners’s Portfolio MOLN Stock Details MOLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-121,247	Closed	-$2.48M	–	223
2021 Q2	$2.48M	Buy	+121,247	New	+$2.41M	0.12%	54

Other funds holding MOLN

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CCM

CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

MIM

Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Hound Partners's MOLN Position: Q3 2021 in Review

Hound Partners sold out of Molecular Partners (MOLN) in Q3 2021, closing a stake of 121,247 shares — an estimated $2.48M sold.

Hound Partners first reported a position in MOLN in Q2 2021 and held it in 1 quarter. The position peaked at $2.48M in Q2 2021. 9 funds tracked by Wall St. Rank hold MOLN as of Q3 2021.

Hound Partners reported no remaining Molecular Partners position as of Q3 2021 after selling out during the quarter.
Hound Partners sold 121,247 Molecular Partners shares in Q3 2021, an estimated $2.48M.
Hound Partners first reported a position in Molecular Partners in Q2 2021 and held it in 1 quarter.
Hound Partners's Molecular Partners position peaked at $2.48M in Q2 2021.
9 funds tracked by Wall St. Rank held Molecular Partners as of Q3 2021.

Based on Hound Partners's 13F filing for Q3 2021, filed 15 Nov 2021.